Open AccessBalancing Hyperkalemia Risks with Clinical Benefits of Renin-Angiotensin-Aldosterone Inhibitors/Mineralocorticoid Receptor Antagonists Blockade: It’s Apples and Oranges
Author(s) -
Silvia J. Leon,
Navdeep Tangri
Publication year - 2022
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0000952022
Subject(s) - hyperkalemia , medicine , kidney disease , discontinuation , mineralocorticoid receptor , intensive care medicine , aldosterone , spironolactone , cardiology